2025
SJR Q1
JCR Q1 · 7,5
6 matched articles
SCIE
Journal detail
Chinese Journal of Natural Medicines
- Publisher
- China Pharmaceutical University
- Country
- China · Asiatic Region
- Type
- journal
- ISSN
-
1875536420956975
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,096
- Quartile Q1
- H-Index 60
- Cites/doc 6,81
- Docs (3y) 286
- Cites (3y) 1.738
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 7,5
- 5Y JIF 5,7
- JCI 1,39
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Complementary and Alternative Medicine Q1
- Drug Discovery Q1
- Medicine (miscellaneous) Q1
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Integrative & Complementary Medicine | Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,096 | 7,5 | 5,7 | 1,39 | Q1 | 60 |
| 2024 | Q1 | Q1 | 0,938 | 4,9 | 4,8 | 1,24 | Q1 | 55 |
| 2023 | Q1 | Q1 | 0,788 | 4 | 3,7 | 1,07 | Q1 | 55 |
| 2022 | Q1 | Q1 | 0,673 | 4,6 | 3,8 | 1,07 | Q1 | 55 |
| 2021 | Q1 | Q2 | 0,569 | 3,9 | 3,3 | 0,96 | Q2 | 55 |
| 2020 | Q1 | Q2 | 0,664 | 3 | 2,9 | 0,87 | Q2 | 55 |
| 2019 | Q1 | Q3 | 0,516 | 2 | 2 | 0,78 | Q2 | 55 |
| 2018 | — | Q2 | — | 1,8 | 2 | 0,73 | Q2 | — |
| 2017 | Q1 | Q2 | 0,587 | 2 | 1,8 | 0,73 | Q2 | 55 |
| 2016 | Q1 | Q2 | 0,528 | 1,7 | — | — | — | 55 |
| 2015 | Q1 | Q2 | 0,506 | 1,4 | — | — | — | 55 |
| 2014 | Q2 | Q3 | 0,411 | 1,1 | — | — | — | 55 |
| 2013 | Q2 | — | 0,325 | — | — | — | — | 55 |
| 2012 | Q2 | — | 0,346 | — | — | — | — | 55 |
| 2011 | Q2 | — | 0,281 | — | — | — | — | 55 |
| 2010 | Q2 | — | 0,236 | — | — | — | — | 55 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q1 | Q1 | 3/48 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 27/356 |
| 2024 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q1 | Q1 | 6/45 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 48/352 |
| 2023 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q1 | Q1 | 8/43 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 82/354 |
| 2022 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q1 | Q1 | 7/28 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 71/278 |
| 2021 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q2 | Q2 | 10/30 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 122/279 |
| 2020 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q2 | Q2 | 11/28 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 166/276 |
| 2019 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q3 | Q2 | 15/28 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 196/271 |
| 2018 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q2 | Q2 | 13/27 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 198/267 |
| 2017 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q2 | Q2 | 11/27 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 175/261 |
| 2016 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q2 | — | 11/26 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 191/257 |
| 2015 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q2 | — | 12/24 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 199/255 |
| 2014 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q3 | — | 16/24 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 211/255 |